Literature DB >> 34337952

Xanthine Derivatives Reveal an Allosteric Binding Site in Methylenetetrahydrofolate Dehydrogenase 2 (MTHFD2).

Lung-Chun Lee1, Yi-Hui Peng1, Hsin-Huei Chang1, Tsu Hsu1, Cheng-Tai Lu1, Chih-Hsiang Huang1, Ching-Cheng Hsueh1, Fang-Chun Kung1, Ching-Chuan Kuo1,2, Weir-Torn Jiaang1, Su-Ying Wu1.   

Abstract

Methylenetetrahydrofolate dehydrogenase 2 (MTHFD2) plays an important role in one-carbon metabolism. The MTHFD2 gene is upregulated in various cancers but very low or undetectable in normal proliferating cells, and therefore a potential target for cancer treatment. In this study, we present the structure of MTHFD2 in complex with xanthine derivative 15, which allosterically binds to MTHFD2 and coexists with the substrate analogue. A kinetic study demonstrated the uncompetitive inhibition of MTHFD2 by 15. Allosteric inhibitors often provide good selectivity and, indeed, xanthine derivatives are highly selective for MTHFD2. Moreover, several conformational changes were observed upon the binding of 15, which impeded the binding of the cofactor and phosphate to MTHFD2. To the best of our knowledge, this is the first study to identify allosteric inhibitors targeting the MTHFD family and our results would provide insights on the inhibition mechanism of MTHFD proteins and the development of novel inhibitors.

Entities:  

Year:  2021        PMID: 34337952     DOI: 10.1021/acs.jmedchem.1c00663

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  2 in total

1.  The catalytic mechanism of the mitochondrial methylenetetrahydrofolate dehydrogenase/cyclohydrolase (MTHFD2).

Authors:  Li Na Zhao; Philipp Kaldis
Journal:  PLoS Comput Biol       Date:  2022-05-25       Impact factor: 4.779

2.  A Cluster of Metabolic-Related Genes Serve as Potential Prognostic Biomarkers for Renal Cell Carcinoma.

Authors:  Shuo Huang; Qihan Luo; Junhao Huang; Jiale Wei; Sichen Wang; Chunlan Hong; Ping Qiu; Changyu Li
Journal:  Front Genet       Date:  2022-07-07       Impact factor: 4.772

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.